GlaxoSmithKline, GSK

GSK’s cancer drug Jemperli gets file acceptance from US FDA

June 6 (Reuters) – GSK (GSK.L) said on Tuesday that the U.S. Food and Drug Administration had granted file acceptance for its cancer drug, Jemperli, when combined with chemotherapy to treat adult patients with certain types of endometrial cancer.

Reporting by Radhika Anilkumar in Bengaluru; Editing by Savio D’Souza

Our Standards: The Thomson Reuters Trust Principles.

Source: Reuters